Morgan Stanley
THTX

Morgan Stanley’s Theratechnologies THTX Stock Holding History

Morgan Stanley’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-858,614
Closed -$2.03M – 8370
2025
Q2 		$2.03M Sell
858,614
-1,364,608
-61% -$3.34M ﹤0.01% 4694
2025
Q1 		$3.11M Sell
2,223,222
-90,547
-4% -$151K ﹤0.01% 4299
2024
Q4 		$4.19M Buy
2,313,769
+59,875
+3% +$81.4K ﹤0.01% 4145
2024
Q3 		$2.79M Buy
2,253,894
+1,661
+0.1% +$2.25K ﹤0.01% 4417
2024
Q2 		$3.15M Buy
2,252,233
+1
+0% +$1 ﹤0.01% 4244
2024
Q1 		$3.74M Sell
2,252,232
-2,266,568
-50% -$3.64M ﹤0.01% 4148
2023
Q4 		$7.32M Buy
4,518,800
+2,258,675
+100% +$3.4M ﹤0.01% 4138
2023
Q3 		$4.86M Buy
+2,260,125
New +$4.84M ﹤0.01% 3766

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $1.9B AUM 24.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Morgan Stanley's THTX Position: Q3 2025 in Review

Morgan Stanley sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 858,614 shares — an estimated $2.03M sold.

Morgan Stanley first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $7.32M in Q4 2023. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Morgan Stanley reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Morgan Stanley sold 858,614 Theratechnologies shares in Q3 2025, an estimated $2.03M.
  • Morgan Stanley first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Morgan Stanley's Theratechnologies position peaked at $7.32M in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.